Author:
Khosravizade Tabasi Hamidreza,Madarshahian Farah,Khoshniat Nikoo Mohsen,Hassanabadi Mohsen,Mahmoudirad Gholamhossein
Abstract
Abstract
Background
Glycaemic control is the main goal of treatment for type 2 diabetic patients. Hyperglycaemia may result in cognitive decline. More family support may increase medication adherence and decrease glycaemic level. The purpose of this study was to determine the impact of family support improvement behavior on anti diabetic medication adherence and cognition in type 2 diabetic patients.
Method
The randomized control trial study was conducted on 91 patients from an outpatient diabetes clinic. They were randomly divided to intervention (n = 45) and control (n = 46) group. Data on the patients’ demographic information and their family gathered using a questionnaire, For two groups Morisky Medication Adherence Scale (MMAS), drug administration part of Diabetes Social Support Questionnaire – family version (DSSQ), Number Connection Test (NCT) were applied and hemoglobin A1C was measured two times in the onset of study and three months later for control group and before and after intervention for intervention group. The key family members of the intervention group were taught according to their educational needs in small groups.
Result
In intervention group mean of NCT score was significantly decreased after intervention (P = 0.006) however in the control group there was no significant difference after three months. In intervention group a significant correlation was noted between DSSQ scores and MMAS scores after intervention(r =0.67, P < 0.001) but, there was no significant correlation in the control group.
Conclusion
Family support instruction based on the educational needs of family members, may improve medication adherence through direct effect and cognitive status with indirect effect.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference43 articles.
1. Tiv M, Viel JF, Mauny F, Eschwége E, Weill A, Fournier C, Fagot-Campagna A, Penfornis A: Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study. PLoS One 2012, 7: e32412. 10.1371/journal.pone.0032412
2. Azizi F: Diabetes mellitus in the Islamic Republic of Iran. IDF bulletin 1996, 41: 38–39.
3. Berger JE, Ahmann AJ, Balfour DC, Owens GS, Beltran R, Bush MA, Culpepper L, Owens GS, Ringel M, Welty FK: Treating to target: implementing an effective diabetes care paradigm for managed care. Am J Manag Care 2010, 16: S4-S35.
4. Liebl A, Mata M, Eschwage E: Evaluation of risk factors for development of complications in type II diabetes in Europe. Diabetologia 2002, 45: S23-S28. 10.1007/s00125-002-0863-0
5. Massi-Benedetti M: The cost of diabetes Type II in Europe: the CODE-2 Study. Diabetologia 2002, 45: S1-S4. 10.1007/s00125-002-0860-3
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献